Chlorhexidine-Alcohol Versus Povidone-Iodine for Cesarean Antisepsis
CAPICA
1 other identifier
interventional
932
1 country
1
Brief Summary
Primary Hypothesis: chlorhexidine gluconate alcohol skin antiseptic preparation is superior to povidone-iodine scrub and paint skin antiseptic preparation for prevention of cesarean related surgical site infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
July 25, 2014
CompletedFirst Posted
Study publicly available on registry
July 29, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedResults Posted
Study results publicly available
July 21, 2022
CompletedJuly 21, 2022
July 1, 2022
2.3 years
July 25, 2014
January 13, 2022
July 18, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Patients With Surgical Site Infection
Number of Patients with Cesarean-Related surgical site infection by Center for Disease Control (CDC) criteria: superficial, deep, organ space.
4 weeks after cesarean delivery
Secondary Outcomes (1)
Number of Patients With Non-infections Surgical Site Complications
4 weeks after cesarean delivery
Study Arms (2)
Chlorhexidine - Isopropyl alcohol
EXPERIMENTALPre-operative skin preparation with Chlorhexidine Gluconate- Isopropyl alcohol
Povidone-Iodine Scrub and Paint
EXPERIMENTALPre-operative skin preparation with Povidone-Iodine Scrub and Paint
Interventions
Applied to skin pre-operatively for surgical site anti-sepsis; regulated as a drug by FDA
Applied to skin pre-operatively for surgical site anti-sepsis; regulated as a drug by FDA
Eligibility Criteria
You may qualify if:
- cesarean delivery
- age 18-65
- ability to consent in English or Spanish
You may not qualify if:
- inability or unwillingness to consent to study participation in English or Spanish
- current incarceration
- pre-operative diagnosis of chorioamnionitis
- perceived inability to complete follow up for data collection
- any prior known allergy or adverse reaction to either study preparation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MetroHealth Medical Center
Cleveland, Ohio, 44109-1998, United States
Related Publications (3)
Darouiche RO, Wall MJ Jr, Itani KM, Otterson MF, Webb AL, Carrick MM, Miller HJ, Awad SS, Crosby CT, Mosier MC, Alsharif A, Berger DH. Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis. N Engl J Med. 2010 Jan 7;362(1):18-26. doi: 10.1056/NEJMoa0810988.
PMID: 20054046BACKGROUNDHadiati DR, Hakimi M, Nurdiati DS, Masuzawa Y, da Silva Lopes K, Ota E. Skin preparation for preventing infection following caesarean section. Cochrane Database Syst Rev. 2020 Jun 25;6(6):CD007462. doi: 10.1002/14651858.CD007462.pub5.
PMID: 32580252DERIVEDSpringel EH, Wang XY, Sarfoh VM, Stetzer BP, Weight SA, Mercer BM. A randomized open-label controlled trial of chlorhexidine-alcohol vs povidone-iodine for cesarean antisepsis: the CAPICA trial. Am J Obstet Gynecol. 2017 Oct;217(4):463.e1-463.e8. doi: 10.1016/j.ajog.2017.05.060. Epub 2017 Jun 7.
PMID: 28599898DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Lack of masking of clinical personnel to treatment assignment.
Results Point of Contact
- Title
- Edward H Springel, MD
- Organization
- Virginia Commonwealth University Health System
Study Officials
- PRINCIPAL INVESTIGATOR
Brian B Mercer, MD
MetroHealth Medical Center/Case Western Reserve
- PRINCIPAL INVESTIGATOR
Edward H Springel, MD
MetroHealth Medical Center/Case Western Reserve
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 25, 2014
First Posted
July 29, 2014
Study Start
March 1, 2014
Primary Completion
July 1, 2016
Study Completion
July 1, 2016
Last Updated
July 21, 2022
Results First Posted
July 21, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share